THU0193 Reestablishment of efficacy of tofacitinib, an oral janus kinase inhibitor, in rheumatoid arthritis patients after temporary discontinuation [PDF]
Jeffrey Kaine +7 more
openalex +1 more source
Managing Acute Severe Ulcerative Colitis in 2025 and Beyond. [PDF]
Goyal MK, Hassan SA, Berinstein JA.
europepmc +1 more source
Tofacitinib in active ulcerative colitis [PDF]
COTTONE, Mario, Orlando A, Papi C.
core +1 more source
Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata. [PDF]
He J, Yao L, Lan N, Zhu L, Lv Y.
europepmc +1 more source
Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]
Ahsan MU +5 more
europepmc +1 more source
JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. [PDF]
Almerri S +3 more
europepmc +1 more source
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update [PDF]
Aletaha, D. (Daniel) +32 more
core +1 more source
Management of Treatment-Resistant Dermatitis Herpetiformis With Tofacitinib: A Case Report. [PDF]
Kazeminejad A, Montazer F, Malekan M.
europepmc +1 more source
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response. [PDF]
Brand EC +12 more
europepmc +1 more source

